Survey of blood stream infections attributable to Gram-positive cocci : Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program.
The SENTRY Antimicrobial Surveillance Program was established in January, 1997 to monitor the predominant pathogens and antimicrobial resistance patterns of nosocomial and community-acquired infections via a network of sentinel hospitals in the United States (30 sites), Canada (eight sites), Latin America (10 sites), and Europe (24 sites).
During the first 12-month study period (January to December, 1997), a total of 9519 blood stream infections (BSI) were reported by SENTRY participants in the U.S. (6150), Canada (1727), and Latin America (1642).
The Gram-positive cocci, Staphylococcus aureus, coagulase-negative staphylococci (CoNS), enterococci, and streptococci accounted for 53.9% (5131 infections) of all BSI (56.5% U.S., 55.7% Canada, and 42.9% Latin America).
The staphylococci, Enterococcus spp., S. pneumoniae, bêta-hemolytic streptococci, and viridans group streptococci accounted for 6 of the top 11 BSI pathogens in the U.S. and Canada, whereas only S. aureus (1st), CoNS (3rd), and Enterococcus spp. (9th) were among the top 11 pathogens in Latin American hospitals.
The results of this survey affirm the importance of Gram-positive cocci as causes of BSI in both North America and Latin America and demonstrate that important antimicrobial resistance exists among isolates of staphylococci, streptococci, and enterococcifrom all three geographic regions.
This includes oxacillin-resistance among S. aureus (26.9% U.S., 29.2% Latin America, and 4.0% Canada) and CoNS (71. (...)
Mots-clés Pascal : Bactérie Gram positif, Epidémiologie, Programme sanitaire, Surveillance sanitaire, Prévalence, Fréquence apparition, Sensibilité résistance, Antibactérien, Antibiotique, Glycopeptide, Amérique Latine, Amérique, Canada, Amérique du Nord, Etats Unis
Mots-clés Pascal anglais : Gram positive bacteria, Epidemiology, Sanitary program, Sanitary surveillance, Prevalence, Occurrence frequency, Sensitivity resistance, Antibacterial agent, Antibiotic, Glycopeptide, Latin America, America, Canada, North America, United States
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0240952
Code Inist : 002A05B11. Création : 16/11/1999.